Kinetics of replication of a partially attenuated virus and of the challenge virus during a three-year intersubtype feline immunodeficiency virus superinfection experiment in cats

Journal of Virology

Volumn 73, Issue 2, 1999, Pages 1518-1527

  Pistello, Mauro ^a   Matteucci, Donatella ^a   Cammarota, Giancarlo ^a   Mazzetti, Paola ^a   Giannecchini, Simone ^a   Del Mauro, Daniela ^a   Macchi, Sabina ^a   Zaccaro, Lucia ^a   Bendinelli, Mauro ^a  

^a UNIVERSITY OF PISA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CAT; CONTROLLED STUDY; FELINE IMMUNODEFICIENCY VIRUS; FEMALE; NONHUMAN; PRIORITY JOURNAL; SUPERINFECTION; T LYMPHOCYTE SUBPOPULATION; VIRUS ATTENUATION; VIRUS LOAD; VIRUS REPLICATION;

EID: 0032902879     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.73.2.1518-1527.1999     Document Type: Article

References (69)

1. Bach, J. M., M. Hurtrel, L. Chakrabarti, J. P. Ganiere, L. Montagner, and B. Hurtrel. 1994. Early stages of feline immunodeficiency virus infection in lymph nodes and spleen. AIDS Res. Hum. Retroviruses 10:1731-1738.
2. Bachmann, M. H., D. L. Sodora, M. Matthiason-Dubard, G. H. Learn, A. G. Rodrigo, P. Mazzetti, E. A. Hoover, and J. I. Mullins. 1997. Genetic diversity of feline immunodeficiency virus: dual infection, recombination, and distinct evolutionary rates between envelope sequence clades. J. Virol. 71:4241-4253.
3. Baldinotti, F., D. Matteucci, P. Mazzetti, C. Giannelli, P. Bandecchi, F. Tozzini, and M. Bendinelli. 1994. Serum neutralization of feline immunodeficiency virus is markedly dependent on passage history of the virus and host system. J. Virol. 68:4572-4579.
4. Barlough, J. E., T. W. North, C. L. Oxford, K. M. Remington, S. Dandekar, M. N. Ellis, and N. C. Pedersen. 1993. Feline immunodeficiency virus infection of cats as a model to test the effect of certain selection pressures on the infectivity and virulence of resultant lentivirus variants. Antiviral Res. 22: 259-272.
5. Beebe, A. M., N. Dua, T. G. Faith, P. F. Moore, N. C. Pedersen, and S. Dandekar. 1994. Primary stages of feline immunodeficiency virus infection: viral dissemination and cellular targets. J. Virol. 68:3080-3091.
6. Bendinelli, M., D. Matteucci, and M. Pistello. Unpublished data.
7. Bendinelli, M., M. Pistello, S. Lombardi, A. Poli, C. Garzelli, D. Matteucci, L. Ceccherini-Nelli, G. Malvaldi, and F. Tozzini. 1995. Feline immunodeficiency virus: an interesting model for AIDS studies and an important cat pathogen. Clin. Microbiol. Rev. 8:87-112.
8. Bendinelli, M., G. Cammarota, D. Del Mauro, F. Maggi, V. Giannini, C. Bergamini, M. Pistello, and D. Matteucci. When reintroduced into natural hosts a tissue culture-adapted lentivirus reverts to the generalized neutralization resistance typical of primary isolates at different times in individual hosts but through changes at the same position of the SU glycoprotein. Submitted for publication.
9. Bishop, S. A., C. R. Stokes, T. J. Gruffydd-Jones, C. V. Whiting, J. E. Humphries, R. Osborne, M. Papanastasopolou, and D. A. Harbour. 1996. Vaccination with fixed feline immunodeficiency virus (FIV) infected cells: protection, breakthrough and specificity of response. Vaccine 14:1243-1250.
10. Bonhoeffer, S., and M. A. Nowak. 1995. Can live attenuated virus work as post-exposure treatment? Immunol. Today 16:131-135.
11. Burke, D. S. 1997. Recombination in HIV: an important viral evolutionary strategy. Emerg. Infect. Dis. 3:253-259.
12. Cammarota, G., L. Da Prato, E. Nicoletti, D. Matteucci, M. Bendinelli, and M. Pistello. 1996. Quantitation of feline immunodeficiency proviruses in doubly infected cats using competitive PCR and a fluorescence-based RFLP. J. Virol. Methods 62:21-31.
13. Cease, K. B., and J. A. Berzofsky. 1994. Toward a vaccine for AIDS: the emergence of immunobiology-based vaccine development. Annu. Rev. Immunol. 12:923-989.
14. Clements, J. E., R. C. Montelaro, M. C. Zink, A. M. Amedee, S. Miller, A. M. Trichel, B. Jagerski, D. Hauer, L. N. Martin, R. P. Bohm, and M. Murphey-Corb. 1995. Cross-protective responses induced in rhesus macaques by immunization with attenuated macrophage-tropic simian immunodeficiency virus. J. Virol. 69:2737-2744.
15. Cuisinier, A. M., V. Mallet, A. Meyer, C. Cladora, and A. Aubert. 1997. DNA vaccination using expression vectors carrying structural genes induces immune response against feline immunodeficiency virus. Vaccine 15:1085-1094.
16. Daniel, M. D., F. Kirchhoff, S. C. Czajak, P. K. Sehgal, and R. C. Desrosiers. 1992. Protective effects of a live attenuated SIV vaccine with a deletion in the nef gene. Science 258:1938-1941.
17. Del Mauro, D., D. Matteucci, S. Giannecchini, F. Maggi, M. Pistello, and M. Bendinelli. 1998. Autologous and heterologous neutralization analysis of primary feline immunodeficiency virus isolates. J. Virol. 72:2199-2207.
18. Denesvre, C., R. Le Grand, F. Boissin-Cans, L. Chakrabarti, B. Hurtrel, B. Vaslin, D. Dormont, and P. Sonigo. 1995. Highly attenuated SIVmac142 is immunogenic but does not protect against SIVmac251 challenge. AIDS Res. Hum. Retroviruses 11:1397-1406.
19. Dunn, C. S., B. Hurtrel, C. Beyer, L. Gloeckler, T. N. Ledger, C. Moog, M. P. Kieny, M. Methali, D. Schmitt, J. P. Gut, A. Kirn, and A. M. Aubertin. 1997. Protection of SIVmac-infected macaque monkeys against superinfection by a simian immunodeficiency virus expressing envelope glycoproteins of HIV type 1. AIDS Res. Hum. Retroviruses 13:913-922.
20. Elder, J. H., and T. R. Phillips. 1995. Feline immunodeficiency virus as a model for development of molecular approaches to intervention strategies against lentivirus infections. Adv. Virus Res. 45:225-247.
21. Fultz, P. N., L. Yue, Q. Wei, and M. Girard. 1997. Human immunodeficiency virus type 1 intersubtype (B/E) recombination in a superinfected chimpanzee. J. Virol. 71:7990-7995.
22. Gegerfelt, A. V., J. Albert, L. M. Manson, K. Brolider, and E. M. Fenyo. 1991. Isolate-specific neutralizing antibodies in patients with progressive HIV-1 related disease. Virology 185:162-168.
23. Giannecchini, S., D. Matteucci, P. Mazzetti, and M. Bendinelli. 1996. Length of incubation time for feline immunodeficiency virus cultures. J. Clin. Microbiol. 34:2036-2038.
24. Haynes, B. F., M. A. Moody, C. S. Heinly, B. Korber, W. A. Millard, and R. M. Scearce. 1995. HIV type 1 V3 region primer-induced antibody suppression is overcome by administration of C4-V3 peptides as a polyvalent immunogen. AIDS Res. Hum. Retroviruses 11:211-221.
25. Hohdatsu, T., S. Okada, K. Motokawa, C. Aizawa, J. K. Yamamoto, and H. Koyama. 1997. Effect of dual-subtype vaccine against feline immunodeficiency virus infection. Vet. Microbiol. 58:155-165.
26. Hosie, M. J., R. Osborne, J. Yamamoto, J. C. Neil, and O. Jarrett. 1995. Protection against homologous but not heterologous challenge induced by inactivated feline immunodeficiency virus vaccines. J. Virol. 69:1253-1255.
27. Hosie, M. J., T. H. Dunsford, A. de Ronde, B. J. Willett, C. A. Cannon, J. C. Neil, and O. Jarrett. 1996. Suppression of virus burden by immunization with feline immunodeficiency virus Env protein. Vaccine 14:405-411.
28. Huisman, W., J. A. Karlas, K. H. J. Siebelink, R. C. Huisman, A. de Ronde, M. J. Francis, G. F. Rimmelzwaan, and A. D. M. E. Osterhaus. 1998. Feline immunodeficiency virus subunit vaccines that induce virus neutralizing anti-bodies but no protection against challenge infection. Vaccine 16:181-187.
29. Kakinuma, S., K. Motokawa, T. Hohdatsu, J. K. Yamamoto, H. Koyama, and H. Hashimoto. 1995. Nucleotide sequence of feline immunodeficiency virus: classification of Japanese isolates into two subtypes which are distinct from non-Japanese subtypes. J. Virol. 69:3639-3646.
30. Kohler, H., J. Goudsmit, and P. Nara. 1992. Clonal dominance: cause for a limited and failing immune response to HIV-1 infection and vaccination. J. Acquired Immune Defic. Syndr. 5:1158-1168.
31. Kyaw-Tanner, M. T., W. K. Greene, H.-S. Park, and W. F. Robinson. 1994. The induction of in vivo superinfection and recombination using feline immunodeficiency virus as the model. Arch. Virol. 138:261-271.
32. Kyaw-Tanner, M. T., and W. F. Robinson. 1996. Quasispecies and naturally occurring superinfection in feline immunodeficiency virus. Arch. Virol. 141: 1703-1713.
33. Leutenegger, C. M., R. Hofmann-Lehman, E. Holznagel, A. M. Cuisinier, C. Wolfensberger, V. Duquesne, J. Cronier, K. Allenspach, A. Aubert, P. Ossent, and H. Lutz. 1998. Partial protection by vaccination with recombinant feline immunodeficiency virus glycoproteins. AIDS Res. Hum. Retroviruses 14:275-283.
34. Lombardi, S., C. Garzelli, M. Pistello, C. Massi, D. Matteucci, F. Baldinotti, G. Cammarota, L. Da Prato, P. Bandecchi, F. Tozzini, and M. Bendinelli. 1994. A neutralizing antibody-inducing peptide of the V3 domain of feline immunodeficiency virus envelope glycoprotein does not induce protective immunity. J. Virol. 68:8374-8379.
35. Lutz, H., R. Hofmann-Lehman, K. Bauer-Pham, E. Holznagel, F. Tozzini, M. Bendinelli, G. Reubel, A. Aubert, D. Davis, B. Cox, and E. Young. 1995. FIV vaccine studies. I. Immune response to recombinant FIV env gene products and outcome after challenge infection. Vet. Immunol. Immunopathol. 46: 103-113.
36. Macchi, S., F. Maggi, C. Di Iorio, A. Poli, M. Bendinelli, and M. Pistello. 1998. Detection of feline immunodeficiency proviral sequences in lymphoid tissues and central nervous system by in situ gene amplification. J. Virol. Methods 73:109-119.
37. Matteucci, D., P. Mazzetti, F. Baldinotti, L. Zaccaro, and M. Bendinelli. 1995. The feline lymphoid cell line MBM and its use for feline immunodeficiency virus isolation and quantitation. Vet. Immunol. Immunopathol. 46: 71-82.
38. Matteucci, D., M. Pistello, P. Mazzetti, S. Giannecchini, D. Del Mauro, L. Zaccaro, P. Bandecchi, F. Tozzini, and M. Bendinelli. 1996. Vaccination protects against in vivo-grown feline immunodeficiency virus even in the absence of detectable neutralizing antibodies. J. Virol. 70:617-622.
39. Matteucci, D., M. Pistello, P. Mazzetti, S. Giannecchini, D. Del Mauro, I. Lonetti, L. Zaccaro, C. Pollera, S. Specter, and M. Bendinelli. 1997. Studies on AIDS vaccination using an ex vivo feline immunodeficiency virus model: protection conferred by a fixed cell vaccine against cell-free and cell-associated challenge differs in duration and is not easily boosted. J. Virol. 71: 8368-8376.
40. Mellors, J. W., C. R. Rinaldo, Jr., P. Gupta, R. M. White, J. A. Todd, and L. A. Kingsley. 1996. Prognosis in HIV-1 predicted by the quantity of virus in plasma. Science 272:1167-1170.
41. O'Brien, T. R., W. A. Blattner, D. Waters, E. Eyster, M. W. Hilgartner, A. R. Cohen, N. Luban, A. Hatzakis, L. M. Aledort, P. S. Rosenberg, W. J. Miley, B. L. Kroner, and J. J. Goedert. 1996. Serum HIV-1 RNA levels and time of development of AIDS in the Multicenter Hemophilia Cohort Study. JAMA 276:105-110.
42. Okada, S., R. Pu, E. Young, W. V. Stoffs, and J. K. Yamamoto. 1994. Superinfection of cats with feline immunodeficiency virus subtypes A and B. AIDS Res. Hum. Retroviruses 10:1739-1746.
43. Osborne, R., M. Rigby, K. Siebelink, J. C. Neil, and O. Jarrett. 1994. Virus neutralization reveals antigenic variation among feline immunodeficiency virus isolates. J. Gen. Virol. 75:3641-3645.
44. Overbaugh, J., P. A. Luciw, and E. A. Hoover. 1997. Models for AIDS pathogenesis: simian immunodeficiency virus, simian-human immunodeficiency virus and feline immunodeficiency virus infections. AIDS 11:S47-S54.
45. Pecoraro, M. R., K. Tomonaga, T. Miyazawa, Y. Kawaguchi, S. Sugita, Y. Tohya, C. Kai, M. E. Etcheverrigaray, and T. Mikami. 1996. Genetic diversity of Argentine isolates of feline immunodeficiency virus. J. Gen. Virol. 77: 2031-2035.
46. Pedersen, N. C. 1993. Feline immunodeficiency virus infection, p. 181-228. In J. A. Levy (ed.), The retroviruses, vol. 2. Plenum Press, New York, N.Y.
47. Petry, H., U. Dittmer, C. Stahl-Hennig, C. Coulibaly, B. Makoschey, D. Fuchs, H. Wachter, T. Tolle, C. Morys-Wortmann, F.-J. Kaup, E. Jurkiewicz, W. Lüke, and G. Hunsmann. 1995. Reactivation of human immunodeficiency virus type 2 in macaques after simian immunodeficiency virus SIVmac superinfection. J. Virol. 69:1564-1574.
48. Pistello, M., S. Menzo, M. Giorgi, L. Da Prato, G. Cammarota, M. Clementi, and M. Bendinelli. 1994. Competitive polymerase chain reaction for quantitating feline immunodeficiency virus load in infected cat tissues. Mol. Cell. Probes 8:229-234.
49. Pistello, M., G. Cammarota, E. Nicoletti, D. Matteucci, M. Curcio, D. Del Mauro, and M. Bendinelli. 1997. Analysis of genetic diversity and phylogenetic relationship of Italian isolates of feline immunodeficiency virus evidences a high prevalence and heterogeneity of subtype B. J. Gen. Virol. 78: 2247-2257.
50. Putkonen, P. L., L. Walther, Y. J. Zhang, S. L. Li, C. Nilsson, J. Albert, P. Biberfeld, R. Thorstensson, and G. Biberfeld. 1995. Long-term protection against SIV-induced disease in macaques vaccinated with a live attenuated HIV-2 vaccine. Nat. Med. 1:914-918.
51. Richardson, J., A. Moraillon, A.-M. Cuisinier, P. Sonigo, and G. Pancino. 1997. Enhancement of feline immunodeficiency virus (FIV) infection after DNA vaccination with the FIV envelope. J. Virol. 71:9640-9649.
52. Richardson, J., A. Moraillon, F. Crespeau, S. Baud, P. Sonigo, and G. Pancino. 1998. Delayed infection after immunization with a peptide from the transmembrane glycoprotein of feline immunodeficiency virus. J. Virol. 72: 2406-2415.
53. Rigby, M. A., N. Mackay, G. Reid, R. Osborne, J. C. Neil, and O. Jarrett. 1996. Immunogenicity of a peptide from a major neutralising determinant of the feline immunodeficiency virus surface glycoprotein. Vaccine 14:1095-1102.
54. Robertson, D. L., P. M. Sharp, F. E. McCutchan, and B. H. Hahn. 1995. Recombination in HIV-1. Nature 374:124-126.
55. Rodrigo, A. G. 1997. Dynamics of syncytium-inducing and non-syncytium-inducing type 1 human immunodeficiency virus during primary infection. AIDS Res. Hum. Retroviruses 13:1447-1451.
56. Sharpe, S. A., A. M. Whatmore, G. A. Hall, and M. P. Cranage. 1997. Macaques infected with attenuated simian immunodeficiency virus resist superinfection with virulence-revertant virus. J. Gen. Virol. 78:1923-1927.
57. Shibata, R., C. Siemon, M. W. Cho, L. O. Arthur, S. Nigida, Jr., T. Matthews, L. A. Sawyer, A. Schultz, K. K. Murthy, Z. Israel, A. Javadian, P. Frost, R. C. Kennedy, H. C. Lane, and M. A. Martin. 1996. Resistance of previously infected chimpanzees to successive challenges with a heterologous intraclade B strain of human immunodeficiency virus type 1. J. Virol. 70:4361-4369.
58. Shibata, R., C. Siemon, S. C. Czajak, R. C. Desrosiers, and M. A. Martin. J997. Live, attenuated simian immunodeficiency virus vaccines elicit potent resistance against a challenge with a human immunodeficiency virus type 1 chimeric virus. J. Virol. 71:8141-8148.
59. Siebelink, K. H. J., E. Tijaar, R. C. Huisman, W. Huisman, A. de Ronde, I. H. Darby, M. J. Francis, G. F. Rimmelzwaan, and A. D. M. E. Osterhaus. 1995. Enhancement of feline immunodeficiency virus infection after immunization with envelope glycoprotein subunit vaccines. J. Virol. 69:3704-3711.
60. Sodora, D. L., E. G. Shpaer, B. E. Kitchell, S. W. Dow, E. A. Hoover, and J. I. Mullins. 1994. Identification of three feline immunodeficiency virus (FIV) env gene subtypes and comparison of the FIV and human immunodeficiency virus type 1 evolutionary patterns. J. Virol. 68:2230-2238.
61. Sparger, E. E., A. M. Beebe, N. Dua, S. Himathongkam, J. H. Elder, M. Torten, and J. Higgins. 1994. Infection of cats with molecularly cloned and biological isolate of the feline immunodeficiency virus. Virology 205:546-553.
62. Taddeo, B., M. Federico, F. Titti, G. B. Rossi, and P. Verani. 1993. Homologous superinfection of both producer and nonproducer HIV-1-infected cells is blocked at a late retrotranscription step. Virology 194:441-452.
63. Tozzini, F., D. Matteucci, F. Bandecchi, F. Baldinotti, A. Poli, M. Pistello, K. H. L. Siebelink, L. Ceccherini-Nelli, and M. Bendinelli. 1992. Simple in vitro methods for titrating feline immunodeficiency virus (FIV) and FIV neutralizing antibodies. J. Virol. Methods 37:241-252.
64. Tozzini, F., D. Matteucci, F. Bandecchi, F. Baldinotti, K. Siebelink, A. Osterhaus, and M. Bendinelli. 1993. Neutralizing antibodies in cats infected with feline immunodeficiency virus. J. Clin. Microbiol. 31:1626-1629.
65. Verschoor, E. J., M. J. Willemse, J. G. Stam, A. L. W. VanVliet, H. Pouwels, S. K. Chalmers, M. C. Horzinek, P. J. A. Sondermeijer, W. Hesselink, and A. de Ronde. 1996. Evaluation of subunit vaccines against feline immunodeficiency virus infection. Vaccine 14:285-289.
66. Volsky, D. J., M. Simm, M. Shahabuddin, G. Li, W. Chao, and M. J. Potash. 1996. Interference to human immunodeficiency virus type 1 infection in the absence of downmodulation of the principal virus receptor, CD4. J. Virol. 70: 3823-3833.
67. Willett, B. J., N. Flynn, and M. J. Hosie. 1997. FIV infection of the domestic cat: an animal model for AIDS. Immunol. Today 18:182-187.
68. Yamamoto, J. K., C. D. Ackley, H. Zochlinski, H. Louie, E. Pembroke, M. Torten, H. Hansen, R. Munn, and T. Okuda. 1991. Development of IL-2-independent feline lymphoid cell lines chronically infected with feline immunodeficiency virus: importance for diagnostic reagents and vaccines. Intervirology 32:361-375.
69. Yamamoto, J. K., T. Hohdatsu, R. A. Olmsted, R. Pu, H. Louie, B. Zochlinski, V. Acevedo, H. M. Johnson, G. A. Soulds, and M. B. Gardner. 1993. Experimental vaccine protection against homologous and heterologous strains of feline immunodeficiency virus. J. Virol. 67:601-605.